Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.25.3
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
OPERATING ACTIVITIES    
Net income $ (22,726,279) $ (37,801,426)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 152,105 268,177
Gain on sale of ENTADFI® assets (10,780,290) (1,222,908)
Loss on sale of FC2 business 4,103,817 0
Noncash change in right-of-use assets 581,453 770,700
Noncash interest expense, net of interest paid (168,556) (97,130)
Gain on extinguishment of debt (8,624,778) 0
Share-based compensation 8,102,177 13,644,405
Deferred income taxes (1,916) 367,182
Provision for obsolete inventory (72,831) 1,566,830
Change in fair value of derivative liabilities 3,138,316 239,000
Change in fair value of equity securities 323,773 176,077
Loss on disposal of fixed assets 0 184,267
Other 58,812 0
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (657,253) 546,203
Decrease in inventories 863,928 986,108
Decrease in prepaid expenses and other assets 397,573 862,039
Decrease in accounts payable (2,760,287) (5,432,411)
(Decrease) increase in accrued expenses and other current liabilities (1,347,500) 3,944,381
Decrease in operating lease liabilities (625,352) (683,827)
Net cash used in operating activities (30,043,088) (21,682,333)
INVESTING ACTIVITIES    
Proceeds from sale of FC2 business, net of costs 16,470,552 0
Cash proceeds from sale of ENTADFI® assets 8,280,290 304,536
Proceeds from sale of equity securities 393,217 0
Capital expenditures (1,083) (158,322)
Net cash provided by investing activities 25,142,976 146,214
FINANCING ACTIVITIES    
Payment on extinguishment of residual royalty agreement liabilities (4,221,611) 0
Proceeds from stock option exercises 0 3,280
Installment payments on premium finance agreement 0 (132,975)
Net cash (used in) provided by financing activities (4,221,611) 36,826,910
Net (decrease) increase in cash, cash equivalents, and restricted cash (9,121,723) 15,290,791
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF YEAR 24,916,285 9,625,494
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR 15,794,562 24,916,285
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 78,548 368,820
Cash paid for interest 332,826 704,600
Schedule of non-cash investing and financing activities:    
Equity securities received from sale of ENTADFI® assets 2,500,000 918,372
Amortization of deferred costs related to common stock purchase agreement 0 164,313
Public Offering [Member]    
FINANCING ACTIVITIES    
Proceeds from sale of shares 0 35,228,564
Jefferies Sales Agreement [Member]    
FINANCING ACTIVITIES    
Proceeds from sale of shares 0 66,551
Common Stock Purchase Agreement [Member]    
FINANCING ACTIVITIES    
Proceeds from sale of shares $ 0 $ 1,661,490